Cytek Biosciences, a US-based provider of instruments for researchers and clinicians, has secured an undisclosed sum in a round co-anchored by two China-focused funds while Chinese brand promotion platform Shopal raised Rmb200 million ($29.17 million) in Series B+ round.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
